Truth Investor
Contributor since: 2016
Why Bitcoin Is Perfect For Most First-Time Investors
Bitcoin, Stocks, Bonds, Houses: It's All A Happy 'Bubble'
How The Bitcoin Bubble Will Pop
Bitcoin Plunges: Here's Why It Will Recover
GBTC Craters During The Bitcoin Price Spike
Bitcoin Spikes With North Korea Tensions - Digital Gold Holds Up?
Gilead: Is Sentiment Changing?
Nvidia: Cut Loose And Take Profits
AT&T: Where Dividends Become Debt
DRAM And NAND Strength Continues, Micron Will Too
The Digital Advertising War: Search And Social
Gilead Will Create Significant Shareholder Wealth
Triforce: Intel, Nvidia, And AMD - Which To Buy?
Geron: Speculative Biotech With Upcoming Catalyst
Snap Inc.: Compelling Short? Not So Fast!
Gilead: Oncology Acquisition Incoming
Gilead: No HCV? No Problem
Gilead's HCV Guidance Wasn't Sandbagged
Nvidia: Earnings Expectations Crushed, Guidance In Line
Gilead: Dreadful Guidance Inspires Fear
Snapchat: Overpriced And Overhyped
Apple: Investor Optimism For 2017
Regulus: RG-101 Hold Stays - What Now?
Johnson & Johnson: Fair Is Fair
Why Gilead Is Undervalued
Rheumatoid Arthritis: The Big 3 And The Future
Apple: No Strategy For Mac
Gilead's HCV NDA Means Nothing
Should Geron Opt-In?
Google: YouTube Poised To Explode
Gilead: M&A Coming Soon
Gilead's HIV Business Is More Cash Cow Than Shining Star
Signal Genetics - Merger Breaths New Life And Reality Will Crush It
RG-101 Clinical Hold Offers Investment Opportunity For Regulus Therapeutics
Stop Panicking About Gilead's Hep-C Competition